Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bacopa + lycopene + astaxanthin + vitamin B12 is a nutraceutical combination designed to support cognitive health and provide neuroprotection, particularly in the aging population. The formulation combines the memory-enhancing properties of *Bacopa monnieri* (water hyssop) with the potent antioxidant effects of the carotenoids lycopene and astaxanthin, and the essential neurological support of vitamin B12. This combination targets oxidative stress and neuroinflammation, which are key drivers of age-related cognitive decline. It was notably investigated in the BLAtwelve Study, a randomized, double-blind, placebo-controlled trial supported by the Menarini Group, which demonstrated significant improvements in executive function and verbal fluency among healthy older adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bacopa + lycopene + astaxanthin + vitamin b12.